Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis-Reference-Cited by-同舟云学术

Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis

Published:2004-03 Issue:1-2 Volume:148 Page:11-23
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Magliozzi Roberta,Columba-Cabezas Sandra,Serafini Barbara,Aloisi Francesca

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference48 articles.

1. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL21 (SLC) at the blood–brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis;Alt;Eur. J. Immunol.,2002

2. Determinants of human B cell migration across brain endothelial cells;Alter;J. Immunol.,2003

3. Chemokines in lymphopoiesis and lymphoid organ development;Ansel;Curr. Opin. Immunol.,2001

4. The role of B cells and autoantibodies in multiple sclerosis;Archelos;Ann. Neurol.,2000

5. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions;Baranzini;J. Immunol.,1999

Cited by 274 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatial Transcriptomics of Meningeal Inflammation Reveals Variable Penetrance of Inflammatory Gene Signatures into Adjacent Brain Parenchyma;2024-06-18

2. Perinatal brain group 3 innate lymphoid cells are involved in the formation of murine dural lymphatics;2024-06-14

3. Meningeal lymphatic vessel crosstalk with central nervous system immune cells in aging and neurodegenerative diseases;Neural Regeneration Research;2024-03-01

4. An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression;Expert Review of Neurotherapeutics;2024-01-18

5. A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-01